FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11558511000001102: Tostran 2% gel (ProStrakan Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
42354301000001116 Tostran 2% gel (ProStrakan Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100619301000001115 Tostran 2% gel (Kyowa Kirin Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tostran 2% gel (ProStrakan Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 4 (CD Anab) true Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) Is a Testosterone 20mg gel true Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) Has active ingredient Testosterone true Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) Is a Tostran true Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) Has specific active ingredient Testosterone true Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tostran 2% gel (ProStrakan Ltd) 60 gram Is pack of False Tostran 2% gel (ProStrakan Ltd) Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) 180 gram 3 x 60g pump Is pack of False Tostran 2% gel (ProStrakan Ltd) Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) 180 gram 3 x 60g pump Has AMP True Tostran 2% gel (ProStrakan Ltd) Inferred relationship Existential restriction modifier
Tostran 2% gel (ProStrakan Ltd) 60 gram Has AMP True Tostran 2% gel (ProStrakan Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start